Page 25 - Service Testing News Today

By Chris Wack Ocugen shares were up 9% at 45 cents after the company said the National Institute of Allergy and Infectious Diseases, a part of the National...

By Ben Glickman Shares of Cytokinetics rose after the company said it expected topline results from its aficamten heart drug trial by the end of the year....

Amgen will continue to seek full approval for its Lumakras cancer drug as a treatment for a form of lung cancer.

By Chris Wack Tenaya Therapeutics shares were up 16% to $2.55 one day after the company said the first patient has been dosed with TN-201 gene therapy for...

Treatment derived from bone marrow shows promise in patients with mild Alzheimer's disease.

The combination vaccine has acceptable side effects and could be ready to launch as early as 2025, according to Moderna.

Moderna Inc. announced positive interim results from a Phase 1/2 trial of its combination vaccine against COVID-19 and flu on Wednesday.

By Josh Beckerman Shares of Nuvalent hit a 52-week high and were recently up 30% after the company reported favorable preliminary data from a clinical trial...

Board agrees to review patent covering certain strengths of blockbuster diabetes drug

By Will Feuer Shares of ALX Oncology jumped after the developer of potential cancer treatments reported an interim analysis of early data from its Phase 2...